Amgen (AMGN) EBITDA Margin (2009 - 2026)
Amgen's EBITDA Margin was 46.01% in Q2 2026, up 2.47 percentage points from 43.55% a year earlier and up 2.13 percentage points from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EBITDA Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amgen's EBITDA Margin was 42.24% through Jun 30, 2026, up 2.97 percentage points year-over-year; for FY2025, it was 38.77%, up 0.32 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -11.34 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 38.45% in FY2024 (-4.01 pp), 42.45% in FY2023 (-6.87 pp), 49.32% in FY2022 (+6.84 pp) and 42.48% in FY2021 (-7.63 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q2 2023.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +2.86 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2022 (a gain of 19.77 percentage points); the worst was Q1 2024 (a drop of 14.11 percentage points).
- Per Business Quant data, AMGN's EBITDA Margin in the three quarters before Q2 2026 was 43.88% (Q1 2026), 39.04% (Q4 2025) and 40.11% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 7.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.01% |
| Mar 31, 2026 | 43.88% |
| Dec 31, 2025 | 39.04% |
| Sep 30, 2025 | 40.11% |
| Jun 30, 2025 | 43.55% |
| Mar 31, 2025 | 31.48% |
| Dec 31, 2024 | 40.81% |
| Sep 30, 2024 | 40.49% |
| Jun 30, 2024 | 39.45% |
| Mar 31, 2024 | 32.09% |
| Dec 31, 2023 | 32.35% |
| Sep 30, 2023 | 42.24% |
| Jun 30, 2023 | 51.25% |
| Mar 31, 2023 | 46.21% |
| Dec 31, 2022 | 45.93% |
| Sep 30, 2022 | 52.57% |
| Jun 30, 2022 | 45.56% |
| Mar 31, 2022 | 53.56% |
| Dec 31, 2021 | 46.10% |
| Sep 30, 2021 | 48.14% |
API Access
Amgen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();